Karen Smith

(Dr. Karen Smith M.D. Ph.D.)

Currently holds positions in Sucampo Pharmaceuticals Inc, Sangamo Therapeutics Inc and Antares Pharma Inc

Positions

Position Company Period
Director Sucampo Pharmaceuticals Inc July 15, 2017 -
Independent Director Sangamo Therapeutics Inc June 26, 2018 -
Independent Director Antares Pharma Inc March 4, 2019 -
Global Head of Research & Development and Chief Medical Officer Jazz Pharmaceuticals PLC April 1, 2015 - March 26, 2018
Karen Smith's trades of Aurinia Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-12 2024-11-11
S Sale
5,241 -29.3%
8.43
USD 44,182 		5,241 -29.3% 8.43 USD 44,182
2021-04-05 2021-04-05
PS Planned sale
641 -28.3%
141.15
USD 90,477 		641 -28.3% 141.15 USD 90,477
2021-04-05 2021-04-05
PS Planned sale
11,223 -83.2%
140.13
USD 1,572,679 		11,223 -83.2% 140.13 USD 1,572,679
2016-07-13 2016-07-13
PP Planned purchase
580 +4.5%
143.63
USD 83,305 		580 +4.5% 143.63 USD 83,305
2016-06-15 2016-06-13
PP Planned purchase
557 +4.5%
149.61
USD 83,335 		557 +4.5% 149.61 USD 83,335
// ... existing code ... // ... rest of the file ...